RESUMEN
Oral ulcers, superficial lesions on the surface of the oral mucosa, have a high incidence rate, and their main symptoms include local pain and erosion. Lipopolysaccharide (LPS)-preconditioned bone marrow mesenchymal stem cells and their secreted exosomes (LPS-pre-Exos) have been shown to promote recovery in various inflammatory conditions and wounds. However, studies documenting LPS-pre-Exos as a therapeutic intervention for oral mucosal-like diseases are lacking. In this study, we prepared a silk fibroin microneedle (MN) patch consisting of LPS-pre-Exos and zeolitic imidazolate framework-8 (ZIF-8) that localized at the tip and base, respectively, and used this MN patch for oral ulcer treatment. Upon insertion into the oral mucosa, continuous LPS-pre-Exos release was observed, which promoted macrophage polarization and tissue healing. Additionally, the ZIF-8 framework in the MN patch facilitated the controlled release of Zn2+, which demonstrated potent antimicrobial properties via synergistic effects. The in vitro experimental results showed that the silk fibroin MN patch can continuously release LPS-pre-Exos and Zn2+ for more than 7 days. Thus, the LPS-pre-Exos and ZIF-8-loaded silk fibroin MN patch exhibited good anti-inflammatory and antibacterial properties, promoting oral ulcer healing, and showed good histocompatibility. Hence, it may represent a potentially valuable strategy for facilitating oral ulcer healing.
Asunto(s)
Exosomas , Fibroínas , Lipopolisacáridos , Células Madre Mesenquimatosas , Agujas , Úlceras Bucales , Fibroínas/química , Fibroínas/farmacología , Animales , Lipopolisacáridos/farmacología , Células Madre Mesenquimatosas/metabolismo , Células Madre Mesenquimatosas/citología , Células Madre Mesenquimatosas/efectos de los fármacos , Exosomas/metabolismo , Exosomas/química , Ratones , Úlceras Bucales/patología , Úlceras Bucales/tratamiento farmacológico , Úlceras Bucales/terapia , Úlceras Bucales/metabolismo , Células RAW 264.7 , Masculino , Antibacterianos/química , Antibacterianos/farmacología , Zeolitas/química , Zeolitas/farmacologíaRESUMEN
OBJECTIVE: To assess the effect of naltrexone on oral mucosal healing using a traumatic ulcer model DESIGN: Wistar rats (n = 112) received distilled water (control) or naltrexone (0.5, 10, or 50 mg/kg/day). Ulcers were induced on the buccal mucosa using a round skin biopsy punch (diameter 6 mm). Euthanasia was performed on days 1, 3, 7, and 14. Healing was assessed by ulcer area, histological scores, histomorphometric analysis (number of polymorphonuclears, mononuclears, and fibroblasts), and collagen percentage. Immunohistochemistry for TLR-2, TLR-4, NF-kB, and CD31 was evaluated. Nociceptive threshold was measured daily. RESULTS: The 50 mg/kg group showed reduced ulcer area on days 1 (p < 0.001), 3 (p < 0.05), and 14 (p < 0.01). In this group, there was, on day 14, an increase in the percentage of reepithelization (p = 0.043) and collagen (p < 0.05), an increase in connective tissue maturation (p = 0.016), and on day 7 an increase in fibroblasts (p < 0.001). The 10 mg/kg dose reduced the ulcer area on day 1 (p < 0.001). The 50 mg/kg group showed lower expression of TLR-4 (p < 0.001) on day 1, NF-kB on days 1 (p < 0.05) and 14 (p < 0.05), and CD31 on day 14 (p < 0.05). The 0.5 and 10 mg/kg doses reduced TLR-4 expression on day 1 (p < 0.05; p < 0.01, respectively). Nociceptive threshold increased in the 50 mg/kg group (p < 0.01). CONCLUSION: Naltrexone enhanced traumatic oral ulcer healing by reducing TLR-4/NF-kB signaling and promoting fibroblast proliferation and collagen deposition. Additionally, naltrexone reduced pain in rats.
Asunto(s)
Mucosa Bucal , FN-kappa B , Naltrexona , Úlceras Bucales , Ratas Wistar , Receptor Toll-Like 4 , Cicatrización de Heridas , Animales , Receptor Toll-Like 4/metabolismo , Naltrexona/farmacología , FN-kappa B/metabolismo , Úlceras Bucales/tratamiento farmacológico , Úlceras Bucales/patología , Ratas , Cicatrización de Heridas/efectos de los fármacos , Masculino , Mucosa Bucal/efectos de los fármacos , Mucosa Bucal/metabolismo , Mucosa Bucal/lesiones , Regulación hacia Abajo , Modelos Animales de Enfermedad , Inmunohistoquímica , Fibroblastos/efectos de los fármacos , Colágeno/metabolismo , Receptor Toll-Like 2/metabolismo , Transducción de Señal/efectos de los fármacosAsunto(s)
Úlceras Bucales , Humanos , Femenino , Úlceras Bucales/etiología , Úlceras Bucales/patología , Labio/patología , MasculinoRESUMEN
Recurrent oral ulcers are common oral mucosal lesions that severely reduce patients' quality of life. Commercial mucoadhesive films are easily disrupted due to oral movement and complex wet environments, thus reducing drug utilization and even causing toxic side effects. Herein, we report a mucoadhesive film composed of Ca2+-crosslinked carboxymethylated cellulose nanofibers and alginate, in which two drugs of dexamethasone (DXM) and dyclonine hydrochloride (DYC) are loaded for the treatment of oral ulcers. The wet films have a high Young's modulus of 7.1 ± 2.6 MPa and a large strain of 53.6 ± 9.8 % and adhere to tissue strongly, which allows them to resist the deformation caused by frequent oral movement. The films also have nice durability against water and excellent biocompatibility. Moreover, the drug release was controlled at different rates. The fast release of DYC facilitates the quick relief of pain, while the slow release of DXM benefits the long-term treatment of wounds. Finally, the animal experiment demonstrates the films displayed excellent therapeutic efficacy in healing oral ulcers.
Asunto(s)
Alginatos , Celulosa , Mucosa Bucal , Nanofibras , Cicatrización de Heridas , Nanofibras/química , Alginatos/química , Cicatrización de Heridas/efectos de los fármacos , Mucosa Bucal/efectos de los fármacos , Mucosa Bucal/metabolismo , Animales , Celulosa/química , Celulosa/análogos & derivados , Dexametasona/química , Dexametasona/farmacología , Liberación de Fármacos , Úlceras Bucales/tratamiento farmacológico , Úlceras Bucales/patología , Humanos , Ratas , Adhesivos/química , MasculinoRESUMEN
BACKGROUND: Oral ulcerative mucositis (OUM) is common in patients with cancer, particularly in those undergoing chemoradiation therapy. The effective management of OUM is crucial for continuous cancer care and patient well-being. Recent studies have advanced our understanding of the causes, leading to clinical trials toward novel treatments. This review focuses on the contemporary therapeutic landscape, and provides the latest insights into the mechanisms of mucosal healing and pain. HIGHLIGHTS: Management strategies for OUM in patients with cancer include maintaining good oral hygiene, reducing mucosal irritation against radiation, and using various topical analgesic treatments, including herbal medicines. However, the current management practices have limitations that necessitate the development of more efficacious and novel treatments. Molecular research on transient receptor potential (TRP) channels in the oral mucosa is crucial for understanding the mechanisms of wound healing and pain in patients with OUM. Targeting TRPV3 and TRPV4 can enhance wound healing through re-epithelialization. The suppression of TRPV1, TRPA1, and TRPV4 may be effective in alleviating OUM-induced pain. CONCLUSION: Research advancements have improved our understanding and potentially led to novel treatments that offer symptomatic relief. This progress highlights the importance of collaborations between clinical researchers and scientists in the development of innovative therapies.
Asunto(s)
Estomatitis , Humanos , Estomatitis/terapia , Estomatitis/etiología , Estomatitis/tratamiento farmacológico , Cicatrización de Heridas/efectos de los fármacos , Úlceras Bucales/tratamiento farmacológico , Úlceras Bucales/terapia , Úlceras Bucales/etiología , Úlceras Bucales/patología , Mucosa Bucal/patología , Mucosa Bucal/efectos de los fármacos , Mucosa Bucal/metabolismoRESUMEN
Extranodal natural killer/T-cell lymphoma is a distinct subtype of non-Hodgkin lymphoma that originates from natural killer cells or cytotoxic T cells. Its diagnosis is challenging due to the rarity and lack of awareness, especially in cases where osteomyelitis of the jawbone is the initial symptom. This paper reports a case of extranodal natural killer/T-cell lymphoma presenting primarily with oral ulcers. Through analyzing the clinical and pathological characteristics, differential diagnosis, treatment and prognosis, and reasons for misdiagnosis of the disease, this study aims to provide references for clinical diagnosis and treatment.
Asunto(s)
Neoplasias del Seno Maxilar , Osteomielitis , Humanos , Osteomielitis/diagnóstico , Osteomielitis/diagnóstico por imagen , Diagnóstico Diferencial , Neoplasias del Seno Maxilar/patología , Neoplasias del Seno Maxilar/diagnóstico , Masculino , Linfoma Extranodal de Células NK-T/patología , Linfoma Extranodal de Células NK-T/diagnóstico , Tomografía Computarizada por Rayos X , Enfermedades Mandibulares/diagnóstico por imagen , Enfermedades Mandibulares/diagnóstico , Enfermedades Mandibulares/patología , Úlceras Bucales/diagnóstico , Úlceras Bucales/patología , Persona de Mediana EdadRESUMEN
This study investigates the efficacy of a thermo-responsive N-acetylcysteine (NAC) hydrogel on wound healing and oral ulcer recovery. Formulated by combining NAC with methylcellulose, the hydrogel's properties were assessed for temperature-induced gelation and cell viability using human fibroblast cells. In vivo experiments on Sprague Dawley rats compared the hydrogel's effects against saline, NAC solution, and a commercial NAC product. Results show that a 5% NAC and 1% methylcellulose solution exhibited optimal outcomes. While modest improvements in wound healing were observed, significant enhancements were noted in oral ulcer recovery, with histological analyses indicating fully regenerated mucosal tissue. The study concludes that modifying viscosity enhances NAC retention, facilitating tissue regeneration. These findings support previous research on the beneficial effects of antioxidant application on damaged tissues, suggesting the potential of NAC hydrogels in improving wound care and oral ulcer treatment.
Asunto(s)
Acetilcisteína , Hidrogeles , Úlceras Bucales , Ratas Sprague-Dawley , Cicatrización de Heridas , Cicatrización de Heridas/efectos de los fármacos , Acetilcisteína/farmacología , Animales , Ratas , Humanos , Hidrogeles/química , Hidrogeles/farmacología , Úlceras Bucales/tratamiento farmacológico , Úlceras Bucales/patología , Regeneración/efectos de los fármacos , Fibroblastos/efectos de los fármacos , Masculino , Temperatura , Supervivencia Celular/efectos de los fármacosRESUMEN
ABSTRACT: Chronic nonhealing ulcers of the oral mucosa and lateral tongue, in particular, can transform into invasive oral squamous cell carcinoma (OSCC). Sometimes these ulcers do not heal even after the removal of the etiological agent that actually initiated these lesions, something similar to what happens in "neoplasia." Numerous factors have been postulated in the literature; however, the exact mechanism remains unclear. We hereby would suggest few plausible factors that could be considered for future studies to shed light on some untapped territories in the pathogenesis of OSCC arising from chronic nonhealing traumatic ulcers in purview of chromoanagenesis and the concepts of "quantum entanglement and coherence."
Asunto(s)
Carcinoma de Células Escamosas , Mucosa Bucal , Neoplasias de la Boca , Úlceras Bucales , Humanos , Neoplasias de la Boca/patología , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/complicaciones , Úlceras Bucales/patología , Úlceras Bucales/etiología , Mucosa Bucal/patología , Boca/patologíaAsunto(s)
Paladar Duro , Femenino , Humanos , Masculino , Biopsia , Diagnóstico Diferencial , Úlceras Bucales/patología , Paladar Duro/patologíaRESUMEN
Oral ulceration is the most common oral mucosal disease. Oral mucosal ulcers are extremely painful, may interfere with eating and speaking, and potentially complicate systemic symptoms in severe cases. The humid and highly dynamic environment of the oral cavity makes local drug administration for treating oral mucosal ulcers challenging. To overcome these challenges, we designed and prepared a novel dissolving microneedle (MN) patch containing multiple drugs in a core-shell to promote oral ulcer healing. The MNs contained a methacrylate gelatin shell layer of basic fibroblast growth factor (bFGF), a hyaluronic acid (HA) core loaded with dexamethasone (DXMS), and zeolite imidazoline framework-8 (ZIF-8) encapsulated in the HA-based backplane. Progressive degradation of gelatin methacryloyl (GelMA) from the tip of the MN patch in the oral mucosa resulted in sustained bFGF release at the lesion site, significantly promoting cell migration, proliferation, and angiogenesis. Moreover, the rapid release of HA and, subsequently, DXMS inhibited inflammation, and the remaining MN backing after the tip dissolved behaved as a dressing, releasing ZIF-8 for its antimicrobial effects. This novel, multifunctional, transmucosal core-shell MN patch exhibited excellent anti-inflammatory, antimicrobial, and pro-healing effects in vivo and in vitro, suggesting that it can promote oral ulcer healing.
Asunto(s)
Gelatina , Ácido Hialurónico , Metacrilatos , Mucosa Bucal , Agujas , Úlceras Bucales , Cicatrización de Heridas , Ácido Hialurónico/química , Gelatina/química , Animales , Úlceras Bucales/tratamiento farmacológico , Úlceras Bucales/patología , Mucosa Bucal/efectos de los fármacos , Mucosa Bucal/metabolismo , Metacrilatos/química , Cicatrización de Heridas/efectos de los fármacos , Ratas , Dexametasona/administración & dosificación , Dexametasona/farmacología , Factor 2 de Crecimiento de Fibroblastos/administración & dosificación , Masculino , Ratones , HumanosRESUMEN
Several topics related to the oral cavity are briefly addressed in this article, from anatomical variations that, when recognized, avoid unnecessary investigations, to diseases that affect exclusively the mouth, mucocutaneous diseases, as well as oral manifestations of systemic diseases. A complete clinical examination comprises the examination of the mouth, and this approach facilitates clinical practice, shortening the path to diagnosis in the outpatient clinic as well as with in-hospital patients. The objective of this article is to encourage the examination of the oral cavity as a useful tool in medical practice, helping to recognize diseases in this location.
Asunto(s)
Enfermedades de la Boca , Úlceras Bucales , Humanos , Enfermedades de la Boca/diagnóstico , Enfermedades de la Boca/patología , Úlceras Bucales/patología , Boca , Mucosa Bucal/patologíaRESUMEN
BACKGROUND: Oral erythroplakia (OE) is a rare oral potentially malignant disorder, that has a high rate of malignant transformation. The definition of OE still lacks uniformity. In particular, lesions that look clinically like erythroplakias, but are histopathologically diagnosed as squamous cell carcinomas are still sometimes called erythroplakias. The purpose of this study is to present demographic and clinicopathologic features of a series of OEs and clinically oral erythroplakia -like squamous cell carcinomas (OELSCC), to study their differences and to discuss the definition of OE. METHODS: A multicenter retrospective case series of OEs and OELSCCs. Descriptive statistics were used to analyze the data. RESULTS: 11 cases of OEs and 9 cases of OELSCCs were identified. The mean age of the OE patients was 71 years and 72.7% were female, while the mean age of the OELSCC patients was 69 years, and all were female. 9% of the OE and 22% of the OELSCC patients had smoked or were current smokers. 72.7% of the OEs and 55.5% of OELSCCs were uniformly red lesions. 63.6% of the OE and 22% of the OELSCC patients had a previous diagnosis of oral lichenoid disease (OLD). The malignant transformation rate of OE was 9% in a mean of 73 months. CONCLUSIONS: OE and OELSCC may arise de novo or in association with OLD. Tobacco and alcohol use were not prevalent in the present cases. The clinical features of OEs and OELSCC are similar, but symptoms, uneven surface and ulceration may be more common in OELSCCs than in OEs. Clinical recognition of OE is important since it may mimic other, more innocuous red lesions of the oral mucosa. The diagnosis of OE requires biopsy and preferably an excision. Clarification of the definition of OE would aid in clinical diagnostics.
Asunto(s)
Carcinoma de Células Escamosas , Eritroplasia , Neoplasias de Cabeza y Cuello , Enfermedades de la Boca , Neoplasias de la Boca , Úlceras Bucales , Lesiones Precancerosas , Humanos , Femenino , Anciano , Masculino , Neoplasias de la Boca/patología , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas de Cabeza y Cuello/patología , Estudios Retrospectivos , Eritroplasia/diagnóstico , Eritroplasia/patología , Eritroplasia/cirugía , Mucosa Bucal/patología , Úlceras Bucales/patología , Neoplasias de Cabeza y Cuello/patología , Leucoplasia Bucal , Lesiones Precancerosas/patologíaRESUMEN
Background: Oral mucosa is encountered by various lesions and normal variants. Some are not to be worried about, whereas others may be of significance. Knowing the prevalence of oral mucosal lesions in a particular region helps better evaluate, diagnose, and, thus, manage these lesions. Objectives: To assess the prevalence and distribution of oral mucosal lesions and normal variants among various age groups, genders, and sites of the orofacial region. Methods: This cross-sectional study was conducted in the Department of Oral Medicine and Radiology, KIST Medical College and Teaching Hospital from January 2021 to March 2021. Three different proformas were designed according to age, gender, and location of lesions for entry as per the WHO's guide. The obtained data were entered into a Microsoft Excel sheet for frequency analysis by SPSS, and the results were tabulated. Results: Among the records of 16572 (9703 (58.55%) males and 6869 (41.44%) females) OPD patients, 3495 (21.08%) (1934 (55.33%) males and 1561 (44.66%) females) had OMLs and 2314 (13.96%) (1626 (70.26%) males and 688 (29.73%) females) had normal mucosal variants. The most commonly seen OML categories were tobacco-associated lesions, i.e., 2056 (34.07%), tongue lesions, i.e., 1598 (26.48%), oral potentially malignant disorders, i.e., 815 (13.50%), ulcers i.e., 728 (12.06%), and infectious lesions, i.e., 256 (4.24%). Conclusion: The Nepalese population has a wide range of oral mucosal lesions and normal variants, and this study has attempted to have baseline data for the same. The most common OML was smoker's melanosis.
Asunto(s)
Enfermedades de la Boca , Úlceras Bucales , Humanos , Masculino , Femenino , Prevalencia , Estudios Transversales , Nepal/epidemiología , Enfermedades de la Boca/epidemiología , Enfermedades de la Boca/patología , Mucosa Bucal/patología , Úlceras Bucales/patología , Hospitales de EnseñanzaRESUMEN
BACKGROUND: We present a case report on desquamative gingivitis diagnosed as linear IgA disease (LAD), which is a rare autoimmune bullous disease exclusively affecting the oral gingiva. The oral mucosa can be impacted by various autoimmune bullous diseases, and our report focuses on this particular manifestation of LAD. CASE PRESENTATION: This patient presented with atypical symptoms, as frequent blister formation on the gingiva was the primary clinical manifestation. A combination of systemic and local treatment was administered to the patient. Following the treatment, there was a significant improvement observed in both the erythema and the bullous lesions on the gingiva. CONCLUSIONS: A more suitable local treatment strategy should be formulated for patients presenting with oral topical lesions, which clinicians can employ effectively.
Asunto(s)
Gingivitis , Úlceras Bucales , Humanos , Encía/patología , Gingivitis/diagnóstico , Mucosa Bucal/patología , Úlceras Bucales/patología , Inmunoglobulina ARESUMEN
Ulceration is a common presenting sign of a wide spectrum of diseases of the oral cavity involving many etiologic factors, such as trauma, infection, neoplasms, medication, and immune related disorders, ranging from self-limited lesions to life-threatening diseases. In most cases, a proper diagnosis can be established based on medical history and clinical features only. Early diagnosis is important as oral ulcerations might be a manifestation of a systemic disease or sometimes even due to a malignant process.
Asunto(s)
Mucosa Bucal , Úlceras Bucales , Humanos , Mucosa Bucal/patología , Úlceras Bucales/diagnóstico , Úlceras Bucales/etiología , Úlceras Bucales/patologíaRESUMEN
BACKGROUND: Oral ulcers represent a full thickness loss of the mucosal epithelium leading to exposure of the submucosal connective tissue. These are common and usually self-limited lesions, although they may sometimes result from neoplasms, most commonly squamous cell carcinoma. Lymphoproliferative disorders may be difficult to diagnose in apthous ulcers since they mimic reactive inflammation. METHODS: This review presents ten rare oral lymphoid proliferations which should not be missed when assessing oral ulcer biopsies. RESULTS: The ten lesions include several with diagnostic cells which look similar to the histiocytes of a reactive inflammatory ulcer, including Rosai-Dorfman disease, reticulohistiocytoma, Langerhans cell histiocytosis, and traumatic ulcerative granuloma. Other lesions, such as EBV-positive mucocutaneous ulcer, extranodal marginal zone lymphoma of mucosal-associated lymphoid tissue, and plasmablastic lymphoma have lymphoid and/or plasma cell differentiation that mimic the reactive lymphocytes and plasma cells found in reactive ulcers. Two dendritic cell lesions, follicular dendritic cell sarcoma and blastic plasmacytoid dendritic cell neoplasm, both have distinct phenotypes which are required to make an accurate diagnosis. CONCLUSION: Each of these lesions are diagnosed by evaluating their histology, along with their phenotypic profile, which is sometimes enhanced by pertinent molecular findings.
Asunto(s)
Trastornos Linfoproliferativos , Úlceras Bucales , Humanos , Úlceras Bucales/patología , Biopsia , Trastornos Linfoproliferativos/patología , HistiocitosRESUMEN
A man in his 60s had irregular gray-white ulcers with a surrounding erythema on the soft palate, uvula, and tonsils that did not improve with oral cefuroxime. He reported sexual contact with 1 male partner over the prior 6 months; history and physical examination findings were otherwise unremarkable. What is the diagnosis and what would you do next?
Asunto(s)
Enfermedades Asintomáticas , Úlceras Bucales , Paladar Blando , Humanos , Masculino , Úlceras Bucales/etiología , Úlceras Bucales/patología , Paladar Blando/patologíaRESUMEN
Over the last two decades the senior author has exclusively applied the technique of extracapsular dissection (ECD) and extended ECD to treat discrete, apparently benign parotid tumours. This article describes both techniques and evaluates their application. Simple principles are described to anticipate unexpected malignant tumours and manage lumps safely by wide excision. A retrospective analysis of 97 consecutive patients with discrete, apparently benign parotid lumps is presented. The tumours were classified using the European Salivary Gland Society (ESGS) classification for benign tumours of the parotid gland. The ECD or extended ECD technique was employed irrespective of tumour site or size. A review of patients was carried out after a minimum of six months post surgery by two independent clinicians. The mean (range) hospital stay was one (0-4) night (median 1). Complications were both modest and transient. The temporary facial nerve injury rate was 5/97 (6%). Other complications included haematoma (n=2), sialocele (n=2), and first-bite syndrome (n=2). Independent review post surgery demonstrated a mean Sunnybrook facial grading system score of 98/100 and a mean Stony Brook scar assessment score of 4.5/5. In this series 5/97 (5%) of discreet mobile lumps concealed a low-grade salivary cancer. Experience with the application of ECD in conjunction with its extended form in 97 consecutive patients with discrete parotid lumps is described. The technique is amenable to all parotid lumps, is not restricted by site or size, and has shown minimal morbidity. The risk of recurrent disease could not be addressed.